Adult T-cell lymphoma/leukaemia developing in a patient with psoriasis treated with long-term cyclosporine [16]

Acta Dermato-Venereologica

Volumn 86, Issue 2, 2006, Pages 184-185

  Watabe, Hidenori ^a   Soma, Yoshinao ^a   Obara, Wataru ^a   Murakami, Noboru ^a   Kawase, Ayumi ^a   Mizukami, Tomoko ^a   Koike, Mitsuru ^a   Shibuya, Yasushi ^a   Mizoguchi, Masako ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL; CYCLOSPORIN; ETRETINATE; METHOTREXATE; PSORALEN; STEROID;

AGED; BONE MARROW BIOPSY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LETTER; LEUKEMIA; LYMPHOID CELL; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PSORIASIS; SEROLOGY; SOUTHERN BLOTTING; T CELL LYMPHOMA; WESTERN BLOTTING;

ADMINISTRATION, ORAL; AGED; CYCLOSPORINE; DERMATOLOGIC AGENTS; HUMANS; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; MALE; PSORIASIS;

EID: 33745774426     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0033     Document Type: Letter

References (15)

1. Shell AG, Disney AP, Matthew TH, Livingston BE, Keogh AM. Lymphoma incidence, cyclosporine, and the evolution and major impact of malignancy following organ transplantation. Transplant Proc 1997; 29: 825-827.
2. Lebwohl M, Ellis C, Gottlieb A, Koo J, Krueger G, Linden K, Shupack J, Weinstein G. Cyclosporine consensus conference: with emphasis on the treatment of psoriasis. J Am Acad Dermatol 1998; 39: 464-475.
3. Nalesnik MA, Jaffe R, Starzl TE, Demetris AJ, Porter K, Burnham JA, et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988; 133: 173-192.
4. Opelz G, Henderson R. Incidence of non-Hodgkin's lymphoma in kidney and heart transplant recipients. Lancet 1993; 342: 1514-1516.
5. Leblond V, Davi F, Charlotte F, Dorent R, Bitker MO, Sutton L, et al. Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity? J Clin Oncol 1998; 16: 2052-2059.
6. Cockburn IT, Krupp P. The risk of neoplasms in patients treated with cyclosporin A. J Autoimmun 1989; 2: 723-731.
7. Paul CF, Ho VC, McGeown C, Christophers E, Schmidtmann B, Guillaume JC, et al. Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study. J Invest Dermatol 2003; 120: 211-216.
8. Krupp P, Monka C. Side effect profile of cyclosporine A in patients treated for psoriasis. Br J Dermatol 1990; 122: 47-56.
9. Koo JY, Kadonaga JN, Wintroub BV, Lozada-Nur FI. The development of B-cell lymphoma in a patient with psoriasis treated with cyclosporine. J Am Acad Dermatol 1992; 26: 836-840.
10. Cliff S, Pettengell R, Gharge S, Marsden RA. B-cell lymphoma developing in a patient on cyclosporine for recalcitrant psoriasis. Br J Dermatol 1999; 140: 763-765.
11. Lelievre JD, Sacre K, Adle-Biassette H, Molinier-Frenkel V, Gaulard P, Papo T. Epstein-Barr virus-associated lymphoproliferative disease after long-standing cyclosporine therapy for psoriasis: a case of spontaneous regression. J Am Acad Dermatol 2005; 52: 24-27.
12. Pielop JA, Jones D, Duvic M. Transient CD30+ nodal transformation of cutaneous T-cell lymphoma associated with cyclosporine treatment. Int J Dermatol 2001; 40: 505-511.
13. Corazza M, Zampino MR, Montanari A, Altieri E, Virgili A. Primary cutaneous CD30+ large T-cell lymphoma in a patient with psoriasis treated with cyclosporine. Dermatology 2003; 206: 330-333.
14. Mahe E, Descamps V, Grossin M, Fraitag S, Crickx B. CD30+ T-cell lymphoma in a patient with psoriasis treated with ciclosporin and infliximab. Br J Dermatol 2003; 149: 170-173.
15. Grossman RM, Chevret S, Abi-Rached J, Blanchet F, Dubertret L. Long-term safety of cyclosporine in the treatment of psoriasis. Arch Dermatol 1996; 132: 623-629.